| Issue Date | Title | Author(s) | Source | WOS | Fulltext/Archive link |
| 2022 | Relative Energy Variation Characteristics Considering Interaction between Waves and Vegetation Structure | Shih, Ruey-Syan ; Li, Chi-Yu ; Weng, Wen-Kai ; Lin, Chih-Hung | WATER-SUI | 0 | |
| 2012 | RETRACTED: Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer (Retracted article. See vol. 129, pg. 2595, 2019) | Kohrt, H. E.; Houot, R.; Weiskopf, K.; Goldstein, M. J.; Scheeren, F.; Czerwinski, D.; Colevas, A. D.; Wen-Kai Weng ; Clarke, M. F.; Carlson, R. W.; Stockdale, F. E.; Mollick, J. A.; Chen, L. P.; Levy, R. | Journal of Clinical Investigation | | |
| 2014 | RETRACTED: Targeting CD137 enhances the efficacy of cetuximab (Retracted article. See vol. 129, pg. 2595, 2019) | Kohrt, H. E.; Colevas, A. D.; Houot, R.; Weiskopf, K.; Goldstein, M. J.; Lund, P.; Mueller, A.; Sagiv-Barfi, I.; Marabelle, A.; Lira, R.; Troutner, E.; Richards, L.; Rajapaska, A.; Hebb, J.; Chester, C.; Waller, E.; Ostashko, A.; Wen-Kai Weng ; Chen, L. P.; Czerwinski, D.; Fu, Y. X.; Sunwoo, J.; Levy, R. | Journal of Clinical Investigation | | |
| 2019 | RETRACTION: Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer (Retraction of Vol 122, Pg 1066, 2012) | Kohrt, H. E.; Houot, R.; Weiskopf, K.; Goldstein, M. J.; Scheeren, F.; Czerwinski, D.; Colevas, A. D.; Wen-Kai Weng ; Clarke, M. F.; Carlson, R. W.; Stockdale, F. E.; Mollick, J. A.; Chen, L. P.; Levy, R. | Journal of Clinical Investigation | | |
| 2019 | RETRACTION: Targeting CD137 enhances the efficacy of cetuximab (Retraction of Vol 124, Pg 2668, 2014) | Kohrt, H. E.; Colevas, A. D.; Houot, R.; Weiskopf, K.; Goldstein, M. J.; Lund, P.; Mueller, A.; Sagiv-Barfi, I.; Marabelle, A.; Lira, R.; Troutner, E.; Richards, L.; Rajapaska, A.; Hebb, J.; Chester, C.; Waller, E.; Ostashko, A.; Wen-Kai Weng ; Chen, L. P.; Czerwinski, D.; Fu, Y. X.; Sunwoo, J.; Levy, R. | Journal of Clinical Investigation | | |
| 2016 | Risk of Non-Melanoma Skin Cancer Following Hematopoietic Cell Transplantation and Voriconazole-Associated Risk | Kuklinski, L. F.; Li, S. F.; Karagas, M. R.; Kwong, B. Y.; Wen-Kai Weng | Blood | | |
| 2005 | Rituximab variants with re-engineered Fc with higher affinity to activating Fc gamma R eliminate the functional difference between Fc gamma R genotypes | Wen-Kai Weng ; Stavenhagen, J.; Koenig, S.; Levy, R. | Blood | | |
| 2001 | Rituximab-induced Annexin-V staining of tumor cells does not predict clinical outcome following Rituximab treatment in follicular non-Hodgkin's lymphoma | Wen-Kai Weng ; Levy, R. | Blood | | |
| 2002 | Rituximab-induced antibody-dependent cellular cytotoxicity (ADCC) in follicular non-Hodgkin's lymphoma | Wen-Kai Weng ; Levy, R. | Blood | | |
| 1995 | SIGNALING THROUGH CD19 ACTIVATES AP1 TRANSCRIPTION FACTORS IN HUMAN B-LINEAGE CELLS | Wen-Kai Weng ; Obrien, D.; Vanness, B.; Lebien, T. W. | Faseb Journal | | |
| 2016 | A Single-Arm PHASE 2A Study of NM-IL-12 (rHu-IL12) in Patients with Mycosis Fungoides-Type CTCL (MF) Undergoing Low-Dose TOTAL Skin Electron BEAM Therapy (LD-TSEBT) | Kim, Y. H.; Hoppe, R. T.; Rook, A. H.; Maity, A.; Geskin, L. J.; Horowitz, D. P.; Finnegan, G.; Khodadoust, M.; Wen-Kai Weng ; Lares, A.; Hong, E. K. J.; Buchanan, M.; Ma, V.; Kha, H.; Lawrence, C. E.; Vainstein, V.; Basile, L. A. | Blood | | |
| 2001 | Studies on modifications of ITO surfaces in OLED devices by Taguchi methods | Liu, J. M.; Lu, P. Y.; Wen-Kai Weng | Materials Science and Engineering B-Solid State Materials for Advanced Technology | | |
| 2020 | Study of a deep draft vessel to enhance onsite installation capability of a jack up type unit operating in the wind farm zone offshore of the Taichung Harbor Taiwan | Y.Z. Kehr; G.A. Chang; G.J. Huang; Wen-Kai Weng | OCEAN ENG | 1 | |
| 2016 | A Study of Long Wave Attenuation over Composite Undulating Breakwaters | Shih, Ruey-Syan ; Weng, Wen-Kai | J COASTAL RES | 5 | |
| 2016 | Study on the Energy Conversion Efficiency Enhancement of a Fixed Point Absorption Wave Converter | Chi-Yu Li ; Fong-Lin Chen; Wen-Kai Weng | | | |
| 2012 | Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma | Chen, A. I.; Negrin, R. S.; McMillan, A.; Shizuru, J. A.; Johnston, L. J.; Lowsky, R.; Miklos, D. B.; Arai, S.; Wen-Kai Weng ; Laport, G. G.; Stockerl-Goldstein, K. | Bone Marrow Transplantation | | |
| 2013 | Targeting CD137 to enhance the antitumor efficacy of cetuximab by stimulation of innate and adaptive immunity | Kohrt, H. E.; Houot, R.; Weiskopf, K.; Goldstein, M.; Lund, P.; Lira, R. R.; Troutner, E.; Richards, L.; Rajapaksa, A.; Ostashko, A.; Wen-Kai Weng ; Chen, L. P.; Colevas, C. A. D.; Sunwoo, J.; Levy, R. | Journal of Clinical Oncology | | |
| 2009 | TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors | Kohrt, H. E.; Turnbull, B. B.; Heydari, K.; Shizuru, J. A.; Laport, G. G.; Miklos, D. B.; Johnston, L. J.; Arai, S.; Wen-Kai Weng ; Hoppe, R. T.; Lavori, P. W.; Blume, K. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood | | |
| 2013 | TLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN | Benjamin, J.; Chhabra, S.; Kohrt, H.; Laport, G. G.; Arai, S.; Johnston, L.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Negrin, R.; Lowsky, R. | Biology of Blood and Marrow Transplantation | | |
| 2014 | Total Lymphoid Irradiation-Antithymocyte Globulin Conditioning and Allogeneic Transplantation for Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms | Benjamin, J.; Chhabra, S.; Kohrt, H. E.; Lavori, P.; Laport, G. G.; Arai, S.; Johnston, L.; Miklos, D. B.; Shizuru, J. A.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R. | Biology of Blood and Marrow Transplantation | | |
